These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 28347846)
1. Supercritical anti-solvent technique assisted synthesis of thymoquinone liposomes for radioprotection: Formulation optimization, in-vitro and in-vivo studies. Ahmad I; Akhter S; Anwar M; Zafar S; Sharma RK; Ali A; Ahmad FJ Int J Pharm; 2017 May; 523(1):398-409. PubMed ID: 28347846 [TBL] [Abstract][Full Text] [Related]
2. [Optimization of Formulation and Process of Paclitaxel PEGylated Liposomes by Box-Behnken Response Surface Methodology]. Shi YJ; Zhang XF; Guo QT Zhong Yao Cai; 2015 Dec; 38(12):2606-10. PubMed ID: 27352544 [TBL] [Abstract][Full Text] [Related]
3. PEGylated Liposomes of Meloxicam: Optimization by Quality by Design, in vitro Characterization and Cytotoxicity Evaluation. Shaji J; Menon I Pharm Nanotechnol; 2017; 5(2):119-137. PubMed ID: 28462699 [TBL] [Abstract][Full Text] [Related]
5. Accelerated clearance of a second injection of PEGylated liposomes in mice. Ishida T; Masuda K; Ichikawa T; Ichihara M; Irimura K; Kiwada H Int J Pharm; 2003 Apr; 255(1-2):167-74. PubMed ID: 12672612 [TBL] [Abstract][Full Text] [Related]
7. Development of risperidone liposomes for brain targeting through intranasal route. Narayan R; Singh M; Ranjan O; Nayak Y; Garg S; Shavi GV; Nayak UY Life Sci; 2016 Oct; 163():38-45. PubMed ID: 27593571 [TBL] [Abstract][Full Text] [Related]
8. In Vitro and in Vivo Behavior of Liposomes Decorated with PEGs with Different Chemical Features. Mastrotto F; Brazzale C; Bellato F; De Martin S; Grange G; Mahmoudzadeh M; Magarkar A; Bunker A; Salmaso S; Caliceti P Mol Pharm; 2020 Feb; 17(2):472-487. PubMed ID: 31789523 [TBL] [Abstract][Full Text] [Related]
9. Targeting of pegylated liposomal mitomycin-C prodrug to the folate receptor of cancer cells: Intracellular activation and enhanced cytotoxicity. Patil Y; Amitay Y; Ohana P; Shmeeda H; Gabizon A J Control Release; 2016 Mar; 225():87-95. PubMed ID: 26809007 [TBL] [Abstract][Full Text] [Related]
11. Thymoquinone in liposomes: a study of loading efficiency and biological activity towards breast cancer. Odeh F; Ismail SI; Abu-Dahab R; Mahmoud IS; Al Bawab A Drug Deliv; 2012 Nov; 19(8):371-7. PubMed ID: 23043626 [TBL] [Abstract][Full Text] [Related]
12. Liposomal topotecan formulation with a low polyethylene glycol grafting density: pharmacokinetics and antitumour activity. Li C; Wang C; Yang H; Zhao X; Wei N; Cui J J Pharm Pharmacol; 2012 Mar; 64(3):372-82. PubMed ID: 22309269 [TBL] [Abstract][Full Text] [Related]
13. The use of PEGylated liposomes to prolong the circulation lifetime of salvianolic acid B. Zhang L; Han L; Sun X; Gao D; Qin J; Wang J Fitoterapia; 2012 Jun; 83(4):678-89. PubMed ID: 22391022 [TBL] [Abstract][Full Text] [Related]
17. Formulation and statistical optimization of intravenous temozolomide-loaded PEGylated liposomes to treat glioblastoma multiforme by three-level factorial design. Vanza J; Jani P; Pandya N; Tandel H Drug Dev Ind Pharm; 2018 Jun; 44(6):923-933. PubMed ID: 29280385 [TBL] [Abstract][Full Text] [Related]
18. Enhanced oral bioavailability of silymarin using liposomes containing a bile salt: preparation by supercritical fluid technology and evaluation in vitro and in vivo. Yang G; Zhao Y; Zhang Y; Dang B; Liu Y; Feng N Int J Nanomedicine; 2015; 10():6633-44. PubMed ID: 26543366 [TBL] [Abstract][Full Text] [Related]
19. Preparation and in vivo safety evaluations of antileukemic homoharringtonine-loaded PEGylated liposomes. Liu D; Xing J; Xiong F; Yang F; Gu N Drug Dev Ind Pharm; 2017 Apr; 43(4):652-660. PubMed ID: 28005445 [TBL] [Abstract][Full Text] [Related]
20. Optimization and Characterization of Thymoquinone-Loaded Liposomes with Enhanced Topical Anti-inflammatory Activity. Mostafa M; Alaaeldin E; Aly UF; Sarhan HA AAPS PharmSciTech; 2018 Nov; 19(8):3490-3500. PubMed ID: 30218265 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]